Science Business

Science Business is the home for posts on the science, business and policy of healthcare, written by people who aren't regular Forbes contributors.
article image
Jul 31, 2018

Regeneron CEO & CSO: The Real Healthcare Problem Is Bigger Than You Think

We have grown increasingly concerned about the current dialogue on the biopharma industry, which tends to focus on short-term issues such as drug pricing, at the complete exclusion of much bigger issues that threaten the long-term health of our nation and the very sustainability of our way of life.

article image
Jul 24, 2018

Pfizer CEO: How The Biopharmaceutical Industry Creates Value (And Jobs) For The U.S. Economy

The most fundamental way in which the industry creates value is by discovering and manufacturing innovative medicines that help people live longer, healthier, more productive lives.

article image
May 29, 2018

Are Social Determinants The Missing Key To Improving Health?

As we think of clinical contributors to health, social determinants of health must become equally as important.

article image
Apr 12, 2018

Novartis CEO: How To Create Cheaper Alternatives To The Most Expensive Drugs

Patients and the entire U.S. healthcare system deserve to benefit from biosimilars.

article image
Oct 27, 2017

How To Cure An Infectious Disease In The World's Poorest Countries

Gilead Sciences EVP Gregg Alton: Can lessons learned from HIV be applied to hepatitis C?